Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
Alimentary Pharmacology & Therapeutics2015Vol. 43(1), pp. 83–95
Citations Over TimeTop 1% of 2015 papers
Iliana Doycheva, Jennifer Y. Cui, P. Nguyen, Eduardo Costa, Jonathan Hooker, Heather Hofflich, Ricki Bettencourt, Sharon S. Brouha, Claude B. Sirlin, Rohit Loomba
Abstract
This proof-of-concept study demonstrates that T2DM has significant rates of both NAFLD and advanced fibrosis. Concomitant screening for NAFLD and advanced fibrosis by using MRI-proton density fat fraction and magnetic resonance elastography in T2DM is feasible and may be considered after validation in a larger cohort.
Related Papers
- → Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in patients with coronary heart disease(2014)13 cited
- → Erratum: Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration-Controlled Transient Elastography(2016)8 cited
- → 984 COMBINATION OF THE MEDIAN AND VARIABILITY OF LIVER STIFFNESS MEASUREMENTS BY TRANSIENT ELASTOGRAPHY IMPROVES THE ACCURACY OF DIAGNOSING ADVANCED FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE(2008)2 cited
- → A199 SCREENING FOR NONALCOHOLIC FATTY LIVER DISEASE BY TRANSIENT ELASTOGRAPHY WITH CONTROLLED ATTENUATION PARAMETER IN UNSELECTED PATIENTS WITH INFLAMMATORY BOWEL DISEASE(2018)1 cited
- Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease(2021)